Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

8 terminated/withdrawn out of 409 trials

Success Rate

91.8%

+5.3% vs industry average

Late-Stage Pipeline

12%

49 trials in Phase 3/4

Results Transparency

4%

4 of 90 completed trials have results

Key Signals

106 recruiting4 with results5 withdrawn

Enrollment Performance

Analytics

N/A
134(54.0%)
Phase 2
45(18.1%)
Phase 4
28(11.3%)
Phase 3
21(8.5%)
Phase 1
10(4.0%)
Early Phase 1
10(4.0%)
248Total
N/A(134)
Phase 2(45)
Phase 4(28)
Phase 3(21)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (409)

Showing 20 of 409 trials
NCT06923280Not ApplicableRecruiting

Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

Role: lead

NCT06329622Phase 3Recruiting

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

Role: lead

NCT07703605Not Yet Recruiting

AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors

Role: lead

NCT07720882Not ApplicableRecruiting

A Clinical Study of a Fully Implanted, Wireless and Functional BCI for Upper-Limb Functional Replacement in Tetraplegia Due to Spinal Cord Injury: Efficacy and Safety

Role: collaborator

NCT07712341Not Yet Recruiting

A Cohort Study on the Integrated Management of Chronic Kidney Disease

Role: lead

NCT07707531Early Phase 1Recruiting

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

Role: lead

NCT07466251Phase 4Not Yet Recruiting

PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

Role: collaborator

NCT06022146Phase 3Recruiting

A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)

Role: lead

NCT07694648Recruiting

Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens

Role: lead

NCT07692399Phase 2Not Yet Recruiting

Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL

Role: lead

NCT06288659Not ApplicableActive Not Recruiting

aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial

Role: lead

NCT04967560Not ApplicableCompleted

The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

Role: collaborator

NCT07685301Not Yet Recruiting

Development and Validation of an AI Foundation Model for CNS Tumor Classification

Role: lead

NCT04962958Phase 2Completed

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Role: collaborator

NCT07672522Recruiting

Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort

Role: lead

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07654634Enrolling By Invitation

Precision Antithrombotic Therapy

Role: collaborator

NCT06902740Phase 4Recruiting

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Role: collaborator

NCT05384444Not ApplicableActive Not Recruiting

Effect of FMD on Colorectal Cancer Patients

Role: collaborator

NCT07644962Not Yet Recruiting

Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control Strategies

Role: lead